World Class CME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
World Class CME designates this live activity for a maximum of 18.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American College of Obstetricians and Gynecologists - has assigned up to 19 cognate credits to this program.
The American Board of Radiology Maintenance of Certification – 18.75 AMA PRA Category 1 Credits™ – AMA credits can be used toward ABR MOC Part 2 requirements.
Nurse Practitioners and RNs – The American Nurses Credentialing Center and the American Academy of Nurse Practitioners Certification Program accept continuing education credits sponsored by organizations, agencies, or educational institutions accredited or approved by the Accreditation Council for Continuing Medical Education (ACCME).
Physician Assistants (PA) – The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
This course qualifies for Category 1 CME for PAs.
Certified Nurse Midwives – The American Midwifery Certification Board Certificate Maintenance Program accepts AMA PRA Category 1 Credits™ to satisfy the contact hours requirement.
Sonographers - American Registry for Diagnostic Medical Sonography (ARDMS) accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME. This course qualifies for Category 1 CME for sonographers. This product (service) is not affiliated with or endorsed by Interleos ™. ARDMS ® and APCA ™ are part of the Interleos ™ family of certification councils. This virtual meeting is not ASRT approved.
World Class CME relies on its CME faculty to provide program content that is evidence based and free of commercial bias. Therefore, in accordance with ACCME standards, any faculty, program director, reviewer, and/or provider industry relationships will be disclosed and resolved. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.